Drug Trial Radar · NCT03791775
Efficacy and Safety of Polidocanol Foam 3% in the Treatment of II Degree Hemorrhoidal Disease
Last checked: Nov 20, 2026Latest source record: Sep 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
183
Actual
Start
Jan 2, 2019
Primary completion
Jun 2, 2019
Study completion Jun 2, 2020
Sponsor
- Lead sponsor
- Societa Italiana di Chirurgia ColoRettaleResearch network
- Sponsor type
- Research network
- Collaborators
- SICCR - Gaetano Gallo
- First posted
- Jan 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hemorrhoidal disease (HD) is one of the oldest and most common proctologic diseases that has been described with an estimated prevalence between 4.4% and 86%. Despite the proposal of three mechanisms that might underlie haemorrhoidal development - the varicose vein theory, the vascular hyperplasia theory and the sliding anal-lining theory, the exact pathophysiology of symptomatic hemorrhoid disease is poorly understood. HD seems to be the most common cause for rectal bleeding, or hematochezia, and the second most frequent cause for severe rectorrhagia after diverticulitis. The blood is bright red and coats the stool at the end of defection. Other symptoms include pain, mucous discharge, itching or the sensation of tissue prolapse. The most widely accepted classification is the Goligher classification: * Grade I: hemorrhoids bleed but do not prolapse out of the anal canal; * Grade II: hemorrhoidal cushions prolapse outside of the anal canal on straining or during bowel movements, but reduce spontaneously; * Grade III: hemorrhoidal cushions prolapse outside the anal canal on straining and require manual reduction; * Grade IV: hemorrhoidal prolapse is irreducible even with manipulation
Conditions
- Second-degree Hemorrhoids
Interventions
Polidocanol foam (Atossisclerol® 3%)Drug
The procedure will be performed in the Sims position or lithotomy position. A modified Blonde-Blanchard technique will be adopted, with the tangential injection of polidocanol foam into the submucosa of the apex of each hemorrhoidal pile, without exceeding three piles, and using a self-lighting open-ended anoscope and a 20-G needle in order to reduce bleeding
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success Rate 1Time frame: 12 months follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Catanzaro
Catanzaro, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.